Low Bowel Pathogen Nosode Liquid
NDC Package 63083-4025-2
Package Information
Low Bowel Pathogen Nosode liquids is for the temporary relief of diarrhea, nausea or vomiting, abdominal pain or cramps, bloating, fatigue, or feelings of discomfort or uneasiness.*. This formulation utilizes a liquid delivery system. Marketed by Professional Complementary Health Formulas, this product is identified by NDC 63083-4025.
Identification & Billing
Clinical Specifications
- AMOEBA PROTEUS 12 [hp_X]/59mL
- ANCYLOSTOMA DUODENALE 12 [hp_X]/59mL
- ASCARIS LUMBRICOIDES 12 [hp_X]/59mL
- CITROBACTER FREUNDII 12 [hp_X]/59mL
- CLOSTRIDIUM BOTULINUM 12 [hp_X]/59mL
- CLOSTRIDIUM PERFRINGENS 12 [hp_X]/59mL
- CRYPTOSPORIDIUM HOMINIS 15 [hp_X]/59mL
- DIPHTHERIAL RESPIRATORY PSEUDOMEMBRANE HUMAN 12 [hp_X]/59mL
- ECHINOCOCCUS GRANULOSUS 12 [hp_X]/59mL
- ENTEROCOCCUS FAECIUM 9 [hp_X]/59mL
- ESCHERICHIA COLI 9 [hp_X]/59mL
- GIARDIA LAMBLIA 12 [hp_X]/59mL
- HELICOBACTER PYLORI 12 [hp_X]/59mL
- NECATOR AMERICANUS 12 [hp_X]/59mL
- PHERETIMA ASPERGILLUM 12 [hp_X]/59mL
Regulatory & Marketing
Hierarchy Structure
- 63083 - Professional Complementary Health Formulas
- 63083-4025 - Low Bowel Pathogen Nosode
- 63083-4025-2 - 59 mL in 1 BOTTLE, DROPPER
- 63083-4025 - Low Bowel Pathogen Nosode
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63083-4025-2 identifies a specific commercial package of 59 ml in 1 bottle, dropper of Low Bowel Pathogen Nosode 4025, a human over the counter drug labeled by Professional Complementary Health Formulas. This liquid is formulated for oral use and contains amoeba proteus; ancylostoma duodenale; ascaris lumbricoides; citrobacter freundii; clostridium botulinum; clostridium perfringens; cryptosporidium hominis; diphtherial respiratory pseudomembrane human; echinococcus granulosus; enterococcus faecium; escherichia coli; giardia lamblia; helicobacter pylori; necator americanus; pheretima aspergillum as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Professional Complementary Health Formulas on August 15, 1984. The current certification is valid through December 31, 2027.
How is this Professional Complementary Health Formulas product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63083402502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.